GlassScriptPhysician profile
Brent Roster
NPI 1720222508
$24,499.88
in general payments reported to CMS, 2019-2025
14 companies · $1,168 in 2025
The $1,168 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $104 · 2021: $1,543 · 2022: $1,655 · 2023: $12K · 2024: $8,199 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $5,292 · Food and Beverage: $2,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,120.47 |
| Travel and Lodging | $5,291.85 |
| Food and Beverage | $2,581.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $18,432.77 | 2021-2025 | |
| Steelhead Surgical INC | $2,516.21 | 2019-2022 | |
| Stryker Corporation | $2,145.75 | 2019-2025 | Prostep, Inbone, Prophecy |
| Encore Medical, LP | $290.67 | 2021-2022 | |
| Medline Industries LP | $266.55 | 2023-2024 | |
| Biomerieux INC | $210.25 | 2022 | |
| Vilex LLC | $170.33 | 2024 | |
| Exactech, INC. | $129.28 | 2023 | |
| Bone Support INC. | $108.75 | 2025 | Cerament G, Ceramentbone Void Filler |
| Medshape, INC. | $104.00 | 2020 | |
| Arthrex, INC. | $70.60 | 2022 | |
| Sioux Surgical INC | $24.39 | 2023 | |
| Bioventus LLC | $18.68 | 2019 | |
| Pacira Therapeutics, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,447.74 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Roster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.